InvestorsHub Logo
Followers 137
Posts 22805
Boards Moderated 0
Alias Born 04/08/2004

Re: marcusl2 post# 496

Tuesday, 08/29/2017 8:59:16 PM

Tuesday, August 29, 2017 8:59:16 PM

Post# of 807

But with a market value of a little less than $350 million, Oxford Bio remains a relative minnow compared with Bluebird Bio , a U.S. rival that uses the same lentiviral gene delivery technology and is worth $4.4 billion.



Read more: http://www.dailymail.co.uk/wires/reuters/article-4816352/Profit-finally-sight-gene-therapy-specialist-Oxford-Bio.html#ixzz4rCCPjrHS
Follow us: @MailOnline on Twitter | DailyMail on Facebook

Good luck and GOD bless,

George